Mr. Stephen Van Deventer reports

PREVECEUTICAL ANNOUNCES CHANGE OF AUDITORS

Preveceutical Medical Inc. has changed its auditor from Smythe LLP, certified public accountants, to Davidson & Company LLP, certified professional accountants, effective Dec. 18, 2024.

Preveceutical's board of directors accepted the resignation of the former auditor and appointed the successor auditor as the new auditor of the company, effective Dec. 18, 2024, and to hold office until the close of the company's next annual general meeting of shareholders.

There were no reservations in the former auditor's audit reports for any financial period during which the former auditor was the company's auditor. There are no reportable events (as the term is defined in National Instrument 51-102 (Continuous Disclosure Obligations)) between the company and the former auditor.

In accordance with National Instrument 51-102, the notice of change of auditor, together with the required letters from the former auditor and the successor auditor, has been reviewed by the company's audit committee and board of directors, and will be filed on SEDAR+ accordingly.

About Preveceutical Medical Inc.

Preveceutical is a health science company focused on developing innovative options for preventive and curative therapies utilizing organic and nature identical products. The company aims to be a leader in the preventive health science sector.

With the completion of three of its research programs, the company is actively working on the development, clinical trials and commercialization of its products, and has filed a number of provisional patent applications to protect the intellectual property from its research programs.

We seek Safe Harbor.